新型因果血浆蛋白与甲状腺功能减退症:大规模血浆蛋白质组孟德尔随机化分析
本研究利用2297种血浆蛋白的蛋白数量性状位点(pQTL)进行大规模血浆蛋白质组孟德尔随机化分析,在发现队列中鉴定出31种与甲状腺功能减退症相关的蛋白,其中13种在验证队列中得到验证。这13种蛋白中9种为风险因素,其余为保护性蛋白;POGLUT1和IFN-lambda-1显示出强共定位证据。作者认为这些蛋白可作为甲状腺功能减退症的早期筛查生物标志物。
要点
- 在发现队列中鉴定出31种与甲状腺功能减退症相关的血浆蛋白,其中13种在验证队列中得到验证。
- 13种验证蛋白中9种为风险因素,包括ISG15、Fc受体样蛋白2、TNF配体超家族成员14、Rab-2A、FcRL3、血栓调节蛋白、IFN-lambda-1、血小板糖蛋白Ibα链和IL-7RA。
- POGLUT1与全血和甲状腺表达数量性状位点强共定位(PP4均为0.978),IFN-lambda-1的两个反式pQTL与甲状腺功能减退症强共定位(PP4均为0.998)。
核心结论
- 采用单变量孟德尔随机化鉴定并验证了13种与甲状腺功能减退症相关的蛋白,强化并扩展了干扰素对该病的作用,部分蛋白可解释凝血系统与甲状腺功能减退症之间的部分关联。
- 作者认为本研究鉴定的蛋白可作为甲状腺功能减退症的早期筛查生物标志物。
研究设计与样本
- 采用2297种血浆蛋白的蛋白数量性状位点(pQTL)进行大规模血浆蛋白质组孟德尔随机化分析,将pQTL分为4组并同时在各组内进行孟德尔随机化分析。
- 显著蛋白在2个不同队列中进行发现和验证,并对孟德尔随机化发现的蛋白进行共定位分析和富集分析。
主要发现
- 发现队列中鉴定出31种蛋白,其中13种在验证队列中得到验证。
- 13种验证蛋白中9种为风险因素(ISG15、Fc受体样蛋白2、肿瘤坏死因子配体超家族成员14、Rab-2A、FcRL3、血栓调节蛋白、干扰素λ-1、血小板糖蛋白Ibα链、IL-7RA),其余为保护性蛋白(蛋白O-葡萄糖基转移酶1(POGLUT1)、肿瘤坏死因子配体超家族成员、3-羟基异丁酰辅酶A水解酶、转铁蛋白受体蛋白1)。
- POGLUT1与全血表达数量性状位点强共定位(共定位后验概率(PP4)=0.978),与甲状腺表达数量性状位点强共定位(PP4=0.978)。
- IFN-lambda-1的两个不同反式pQTL(rs2111485 PP4=0.998;rs35103715 PP4=0.998)在不同染色体上与甲状腺功能减退症强共定位。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Although several risk proteins for hypothyroidism have been reported in recent years, many more plasma proteins have not been tested. OBJECTIVE: To determine potential mechanisms and novel causal plasma proteins for hypothyroidism using Mendelian randomization (MR). METHODS: A large-scale plasma proteome MR analysis was conducted using protein quantitative trait loci (pQTLs) for 2297 plasma proteins. We classified pQTLs into 4 different groups. MR analyses were conducted within the 4 groups simultaneously. Significant proteins were discovered and validated in 2 different cohorts. Colocalization analysis and enrichment analysis were conducted using proteins found with MR. RESULTS: Thirty-one proteins were identified in the discovery cohort. Among them, 13 were validated in the validation cohort. Nine of the 13 proteins are risk factors (ISG15, Fc receptor-like protein 2, tumor necrosis factor ligand superfamily member 14, Rab-2A, FcRL3, thrombomodulin, interferon [IFN]-lambda-1, platelet glycoprotein Ib alpha chain, IL-7RA) for hypothyroidism, whereas others are protective proteins (protein O-glucosyltransferase 1 [POGLUT1], tumor necrosis factor ligand superfamily, 3-hydroxyisobutyryl-CoA hydrolase, transferrin receptor protein 1). Among the significant proteins, POGLUT1 strongly colocalized with expression quantitative trait loci from whole blood (posterior probability of colocalization [PP4] = 0.978) and the thyroid (PP4 = 0.978). Two different trans-pQTLs (rs2111485 PP4 = 0.998; rs35103715 PP4 = 0.998) for IFN-lambda-1 strongly colocalized with hypothyroidism in different chromosomes. CONCLUSION: Thirteen various proteins were identified and validated to be associated with hypothyroidism using univariable MR. We reinforced and expanded the effect of IFN on hypothyroidism. Several proteins identified in this study could explain part of the association between the coagulation system and hypothyroidism. Our study broadens the causal proteins for hypothyroidism and provides the relationships between plasma proteins and hypothyroidism. The proteins identified in this study can be used as early screening biomarkers for hypothyroidism.
引用
- Yang H, Chen L, Liu Y, et al. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis. J Clin Endocrinol Metab. 2023. PMID: 36190832. doi:10.1210/clinem/dgac575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。